Fernandes Henrique Veiga

LiMM Therapeutics SA operates as a biopharmaceutical corporation, that specializes in molecular cross-talk between neuronal and innate lymphoid cells within peripheral tissues. The firm develops medicines against inflammatory, infectious, and metabolic diseases. The company was founded by David Braga Malta and Henrique Veiga Fernandes and is headquartered in Paris, France.

StemCell2MAX engages in the provision of proprietary set of expansion solutions for hematopoietic stem cells (HSCs). The company was founded by Maria Brandão de Vasconcelos, Filipa Matos Baptista, Henrique Veiga-Fernandes, Diogo Fonseca-Pereira, and Sílvia Arroz-Madeira in 2015 and is headquartered in Cantanhede, Portugal.

StemCell2MAX engages in the provision of proprietary set of expansion solutions for hematopoietic stem cells (HSCs). The company was founded by Maria Brandão de Vasconcelos, Filipa Matos Baptista, Henrique Veiga-Fernandes, Diogo Fonseca-Pereira, and Sílvia Arroz-Madeira in 2015 and is headquartered in Cantanhede, Portugal.

StemCell2MAX engages in the provision of proprietary set of expansion solutions for hematopoietic stem cells (HSCs). The company was founded by Maria Brandão de Vasconcelos, Filipa Matos Baptista, Henrique Veiga-Fernandes, Diogo Fonseca-Pereira, and Sílvia Arroz-Madeira in 2015 and is headquartered in Cantanhede, Portugal.

StemCell2MAX engages in the provision of proprietary set of expansion solutions for hematopoietic stem cells (HSCs). The company was founded by Maria Brandão de Vasconcelos, Filipa Matos Baptista, Henrique Veiga-Fernandes, Diogo Fonseca-Pereira, and Sílvia Arroz-Madeira in 2015 and is headquartered in Cantanhede, Portugal.